Back to TEVA Stock Lookup

Teva Pharma (TEVA) –

Mar 5, 2015 09:08 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Mar 05
Mar 5, 2015 09:01 AM Teva to Present at the Barclays Global Healthcare Conference
Mar 5, 2015 08:45 AM ANI Pharma (ANIP) Acquires Approved Flecainide Acetate ANDA
Mar 2, 2015 08:29 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Mar 02
Mar 2, 2015 08:22 AM Teva Announces Sale of Sellersville, PA Facility
Feb 27, 2015 08:41 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 27
Feb 27, 2015 08:30 AM Teva Announces Early Results of Debt Tender Offer, Pricing, Election of Early Settlement and Increase in Maximum Amount and Priority 2 Notes Tender Cap
Feb 26, 2015 08:10 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 26
Feb 26, 2015 08:00 AM Teva to Present at the Cowen & Company 35th Annual Healthcare Conference
Feb 25, 2015 08:21 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 25
Feb 25, 2015 08:00 AM Teva Announces FDA Acceptance for Review of NDA for its Investigational Twice-Daily Hydrocodone Bitartrate Extended-Release Tablets with Proprietary Abuse Deterrence Technology
Feb 24, 2015 10:06 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 24
Feb 24, 2015 09:08 AM Adamis Pharmaceuticals (ADMP) Issues Update on APC-1000 PK Study
Feb 24, 2015 09:03 AM Teva Pharma (TEVA) Reports TEV-48125 Phase 2b Met Primary, Secondary Endpoints
Feb 24, 2015 09:00 AM Teva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary Endpoints
Feb 23, 2015 03:15 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 23
Feb 23, 2015 03:05 PM Teva Pharma (TEVA) Phase III Reslizumab Data Published in The Lancet Respiratory Medicine
Feb 23, 2015 03:00 PM The Lancet Respiratory Medicine and AAAAI Publish Positive Data from Phase III Trials of Teva’s Reslizumab for the Treatment of Moderate to Severe Asthma in Patients with Elevated Blood Eosinophils
Feb 20, 2015 08:16 AM Teva Pharma (TEVA) Plans to Present at AAAAI Annual Meeting; Will Include Two Reslizumab Phase 2s
Feb 20, 2015 08:14 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 20
Feb 20, 2015 08:00 AM Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
Feb 19, 2015 12:51 PM Teva Pharma (TEVA): Court Mandate Issued in Capaxone Case
Feb 17, 2015 05:30 PM Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Teva Pharmaceutical Industries Ltd. Stockholders
Feb 17, 2015 04:01 PM Eagle Pharmaceuticals, Inc. Reports Financial Results for Three Month Period Ended December 31, 2014
Feb 17, 2015 10:03 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 17
Feb 17, 2015 08:31 AM Teva Pharma (TEVA) Announces U.S. Launch of Generic Lovenox, Zyvox
Feb 17, 2015 08:30 AM Teva Bolsters Injectable Portfolio with Launch of Generic Lovenox® and Generic Zyvox® in the United States
Feb 17, 2015 07:13 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 17
Feb 17, 2015 07:05 AM Eagle Pharmaceuticals to Hold Conference Call at 8:30 a.m. EST Today to Discuss Licensing Agreement with Teva to Commercialize Eagle’s Rapid Infusion Bendamustine
Feb 17, 2015 07:03 AM Teva Pharma (TEVA), Eagle Pharma (EGRX) Enter EP-310 Licensing Agreement
Feb 17, 2015 07:00 AM Teva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine Rapid Infusion Product
Feb 13, 2015 01:59 PM Form SC 13G/A TEVA PHARMACEUTICAL INDU Filed by: Capital Research Global Investors
Feb 12, 2015 09:08 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 12
Feb 12, 2015 08:26 AM Teva Announces $1 Billion Debt Tender Offer
Feb 10, 2015 01:50 PM Teva Pharma (TEVA) Files Mixed Shelf
Feb 10, 2015 07:04 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 10
Feb 10, 2015 02:51 AM Teva Files 2014 Annual Report on Form 20-F
Feb 5, 2015 08:26 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 05
Feb 5, 2015 07:05 AM Teva Pharma (TEVA) Declares $0.34 Quarterly Dividend; 2.4% Yield
Feb 5, 2015 07:05 AM Teva Pharma (TEVA) Reports In-Line Q4 EPS
Feb 5, 2015 07:01 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 04
Feb 5, 2015 07:00 AM Teva Reports Fourth Quarter and Full Year 2014 Results
Feb 5, 2015 06:30 AM Teva Thanks Dr. Phillip Frost for Board Service
Feb 4, 2015 03:50 PM Trading Radar for 2/4: Twitter (TWTR), GoPro (GPRO), LinkedIn (LNKD), Kors (KORS), Philip Morris (PM) Report
Feb 2, 2015 08:05 AM Intellipharmaceutics International (IPCI) Enters License Agreement with Teva (TEVA)
Jan 26, 2015 03:42 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Jan 26
Jan 26, 2015 03:23 PM Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States
Jan 26, 2015 02:31 PM Teva Pharma (TEVA): FDA Approves First Generic Esomeprazole
Jan 26, 2015 10:47 AM Notable Analyst Rating Changes 1/26: (BBBY) (GRMN) (FNFG) Upgraded; (HCP) (STT) (LYB) Downgraded
Jan 26, 2015 07:17 AM Berenberg Starts Teva Pharma (TEVA) at Sell

Back to TEVA Stock Lookup